Publications by authors named "Christophe Hezode"

Claim this Profile
E
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.
Steven Flamm, Eric Lawitz, Brian Borg, Michael Charlton, Charles Landis

Viruses· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and monitoring of hepatitis C virus infection using the cobas® HCV test for use on the cobas® 4800 system.
Valérie Ortonne, Mélanie Wlassow, Christophe Hézode, Murielle François, Isabelle Rosa

J Clin Virol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of rapid diagnostic tests for HCV infection in serum or plasma.
Stéphane Chevaliez, Françoise Roudot-Thoraval, Christophe Hézode, Jean-Michel Pawlotsky, Richard Njouom

Future Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma.
Stéphane Chevaliez, Françoise Roudot-Thoraval, Christophe Hézode, Jean-Michel Pawlotsky, Richard Njouom

Diagn Microbiol Infect Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
Denis Ouzan, Dominique Larrey, Dominique Guyader, André-Jean Remy, Ghassan Riachi

Dig Dis Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.
Anais Vallet-Pichard, Jean-Michel Correas, Celine Dorival, Fabien Zoulim, Albert Tran, Christophe Hezode

Clin Res Hepatol Gastroenterol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: now is the time to remove complexity from HCV guidelines to ensure that elimination remains a priority.
Juan Turnes, Christophe Hezode, Candido Hernandez, Alessandra Mangia

Aliment Pharmacol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Xpert HBV Viral Load for hepatitis B virus molecular testing.
Lila Poiteau, Mélanie Wlassow, Christophe Hézode, Jean-Michel Pawlotsky, Stéphane Chevaliez

J Clin Virol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance assessment of a fully automated deep sequencing platform for HCV resistance testing.
Christophe Rodriguez, Mélanie Mercier-Darty, Alexandre Soulier, Lila Poiteau, Mélanie Wlassow

Antivir Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs.
Stéphane Chevaliez, Mélanie Wlassow, Johann Volant, Françoise Roudot-Thoraval, Antoine Bachelard

Open Forum Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
Tarik Asselah, Stanislas Pol, Christophe Hezode, Veronique Loustaud-Ratti, Vincent Leroy

Liver Int· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial.
Gregory J Dore, Jordan J Feld, Alex Thompson, Marianne Martinello, Andrew J Muir, Christophe Hezode

J Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy.
Giuliana Amaddeo, Cong Trung Nguyen, Pascale Maillé, Sebastien Mulé, Alain Luciani

Liver Int· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy.
Christophe Hézode, Paul Kwo, Jan Sperl, Peggy Hwang, Jianmin Long

Int J Womens Health· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder.
Jean-Baptiste Trabut, Camille Barrault, Hélène Charlot, Damien Carmona, Anne Bourdel

J Addict Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens.
Mélanie Wlassow, Lila Poiteau, Françoise Roudot-Thoraval, Isabelle Rosa, Alexandre Soulier

J Clin Virol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy.
Jason Grebely, Gregory J Dore, Negar N Alami, Brian Conway, John F Dillon

Int J Drug Policy· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Fabrice Carrat, Hélène Fontaine, Céline Dorival, Mélanie Simony, Alpha Diallo, Christophe Hezode

Lancet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
Anne Laurain, Sophie Metivier, Georges Haour, Dominique Larrey, Céline Dorival, Christophe Hezode

BMC Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Patrice Cacoub, Si Nafa Si Ahmed, Yasmina Ferfar, Stanislas Pol, Dominique Thabut, Christophe Hezode

Clin Gastroenterol Hepatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r.
Slim Fourati, Christophe Rodriguez, Christophe Hézode, Alexandre Soulier, Isaac Ruiz

Hepatology· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes.
Patrice Cacoub, Marc Bourliere, Tarik Asselah, Victor De Ledinghen, Philippe Mathurin

Value Health· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.
Massimo Puoti, Graham R Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Hezode

J Hepatol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C: Results in real life.
Christophe Hézode

Liver Int· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.
Andrew H Talal, Emily O Dumas, Barbara Bauer, Richard M Rejman, Andrew Ocque

J Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis